|
US5770617A
(en)
*
|
1996-03-20 |
1998-06-23 |
Rutgers, The State University Of New Jersey |
Terbenzimidazoles useful as antifungal agents
|
|
US5935982A
(en)
*
|
1997-02-28 |
1999-08-10 |
The University Of North Carolina At Chapel Hill |
Methods of treating retroviral infection and compounds useful therefor
|
|
US6635668B1
(en)
*
|
1998-07-22 |
2003-10-21 |
The University Of North Carolina At Chapel Hill |
Imidazoline receptor binding compounds
|
|
CA2344445A1
(en)
*
|
1998-09-17 |
2000-03-23 |
The University Of North Carolina At Chapel Hill |
Antifungal activity of dicationic molecules
|
|
EP1685836A3
(en)
*
|
1998-09-17 |
2007-05-09 |
University Of North Carolina At Chapel Hill |
Antifungal activity of dicationic molecules
|
|
EP1165096B1
(en)
*
|
1999-03-29 |
2009-09-09 |
Shire Canada Inc. |
Use of cytidine derivatives for the treatment of leukaemia
|
|
DK1231910T3
(da)
*
|
1999-11-16 |
2009-08-31 |
Oncozyme Pharma Inc |
Pentamidin til behandling af cancer
|
|
US7115665B1
(en)
|
2000-11-16 |
2006-10-03 |
Onocozyme Pharma, Inc. |
Inhibitors of endo-exonuclease activity for treating cancer
|
|
US7156809B2
(en)
|
1999-12-17 |
2007-01-02 |
Q-Tec Systems Llc |
Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity
|
|
US6677377B2
(en)
*
|
2000-06-21 |
2004-01-13 |
Georgetown University School Of Medicine |
Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions
|
|
US6569853B1
(en)
*
|
2000-11-06 |
2003-05-27 |
Combinatorx, Incorporated |
Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
|
|
US6706754B2
(en)
*
|
2000-11-06 |
2004-03-16 |
The United States Of America As Represented By The Secretary Of The Army |
Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
|
|
MXPA04001153A
(es)
*
|
2001-08-31 |
2005-02-17 |
Neurochem Int Ltd |
Derivados de amidina para tratar la amiloidosis.
|
|
AU2003302218A1
(en)
|
2002-05-16 |
2004-06-18 |
Genelabs Technologies, Inc |
Aryl and heteroaryl compounds as antibacterial and antifungal agents
|
|
MXPA04012628A
(es)
*
|
2002-06-13 |
2005-03-23 |
Patricia Olivershaffer |
DERIVADOS Y COMPUESTOS RELACIONADOS DEL áCIDO 2-UREIDO-6-HETEROARIL-3H-BENZOIMIDAZOL-4-CARBOXILICO COMO INHIBIDORES DE GIRASA Y/O TOPOISOMERASA IV PARA EL TRATAMIENTO DE INFECCIONES BACTERIALES.
|
|
US7582641B2
(en)
*
|
2003-01-31 |
2009-09-01 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
AR042956A1
(es)
*
|
2003-01-31 |
2005-07-13 |
Vertex Pharma |
Inhibidores de girasa y usos de los mismos
|
|
US7618974B2
(en)
*
|
2003-01-31 |
2009-11-17 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
US8404852B2
(en)
|
2003-01-31 |
2013-03-26 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
US7569591B2
(en)
*
|
2003-01-31 |
2009-08-04 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
US8193352B2
(en)
*
|
2003-01-31 |
2012-06-05 |
Vertex Pharmaceuticals Incorporated |
Gyrase inhibitors and uses thereof
|
|
US20050054708A1
(en)
*
|
2003-07-28 |
2005-03-10 |
Nichols Matthew James |
Combinations of drugs for the treatment of neoplasms
|
|
US20050080075A1
(en)
*
|
2003-08-25 |
2005-04-14 |
Nichols M. James |
Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
|
|
US20050100508A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Nichols M. J. |
Methods for identifying drug combinations for the treatment of proliferative diseases
|
|
US20050158320A1
(en)
*
|
2003-11-12 |
2005-07-21 |
Nichols M. J. |
Combinations for the treatment of proliferative diseases
|
|
US7262223B2
(en)
*
|
2004-01-23 |
2007-08-28 |
Neurochem (International) Limited |
Amidine derivatives for treating amyloidosis
|
|
WO2005089370A2
(en)
|
2004-03-16 |
2005-09-29 |
Goodis Charles J |
Endodontic files and obturator devices and methods of manufacturing same
|
|
US7459457B2
(en)
|
2004-04-13 |
2008-12-02 |
Icagen, Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
|
DE102004031656A1
(de)
*
|
2004-06-30 |
2006-01-19 |
Merck Patent Gmbh |
Tetrahydrochinoline
|
|
US7817792B2
(en)
*
|
2006-05-04 |
2010-10-19 |
Microsoft Corporation |
Hyperlink-based softphone call and management
|
|
DE102007013856A1
(de)
|
2007-03-20 |
2008-09-25 |
Merck Patent Gmbh |
Substituierte Tetrahydropyrrolochinoline
|
|
DE102007013854A1
(de)
|
2007-03-20 |
2008-09-25 |
Merck Patent Gmbh |
Tetrahydrochinoline
|
|
DE102007013855A1
(de)
|
2007-03-20 |
2008-09-25 |
Merck Patent Gmbh |
Substituierte Tetrahydrochinoline
|
|
EP2194981B1
(en)
*
|
2007-10-05 |
2011-11-23 |
Université de Mons-Hainaut |
Bisbenzimidazoles as antimalarial agents
|
|
US8748618B2
(en)
|
2009-05-13 |
2014-06-10 |
University Of Virginia Patent Foundation |
Inhibitors of inv(16) leukemia
|
|
RU2625305C2
(ru)
|
2011-01-14 |
2017-07-13 |
Сперо Тринем, Инк. |
Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины
|
|
JP6085829B2
(ja)
|
2011-01-14 |
2017-03-01 |
スペロ トリネム， インコーポレイテッド |
ピリミジンジャイレースおよびトポイソメラーゼｉｖ阻害剤
|
|
PT2663556E
(pt)
|
2011-01-14 |
2014-11-27 |
Vertex Pharma |
Processo de fabrico de inibidores de girase e topoisomerase iv
|
|
EP2663558A1
(en)
|
2011-01-14 |
2013-11-20 |
Vertex Pharmaceuticals Incorporated |
Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea
|
|
WO2012177707A1
(en)
|
2011-06-20 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Phosphate esters of gyrase and topoisomerase inhibitors
|
|
US9018216B2
(en)
|
2012-07-18 |
2015-04-28 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
|
|
WO2014014845A1
(en)
|
2012-07-18 |
2014-01-23 |
Vertex Pharmaceuticals Incorporated |
Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
HK1248235A1
(zh)
*
|
2015-05-15 |
2018-10-12 |
吉利德科学公司 |
具有作为吲哚胺2，3-二加氧酶抑制剂活性的苯并咪唑和咪唑并吡啶亚氨代甲酰胺化合物
|
|
EA201990395A1
(ru)
|
2016-07-27 |
2019-07-31 |
Юниверсити Оф Вирджиния Пэйтент Фаундейшн |
Варианты комбинированной терапии для лечения рака
|
|
US20200030295A1
(en)
*
|
2016-08-02 |
2020-01-30 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Heterocyclic diamidines
|